Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791786 · ClinicalTrials.gov registry record
The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)
A clinical trial of Amniotic Fluid Embolism, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT05791786: Recruiting study of Amniotic Fluid Embolism, sponsored by The University of Texas Health Science Center, Houston.
NCT05791786 is a study of Amniotic Fluid Embolism that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05791786, a study of Amniotic Fluid Embolism, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,
Primary Outcome
The existing registry will be migrated to a new platform, thus to enhance and strengthen the content and the quality of the data obtained.
Conditions Studied
Interventions
- OTHER Patient
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2031-12-31 |
What NCT05791786 shows while recruiting
NCT05791786 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Amniotic Fluid Embolism appearing as the primary indexed condition, and to 1 intervention - of which Patient is the first listed.
NCT05791786 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05791786 about?
NCT05791786 is a clinical study titled "The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)". To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,
What is the current status of trial NCT05791786?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2022-07-05. Estimated completion is 2031-12-31.
What conditions does trial NCT05791786 study?
This clinical trial studies the following conditions: Amniotic Fluid Embolism.
What interventions are being tested in trial NCT05791786?
The interventions under investigation include: Patient (OTHER).
Who is sponsoring clinical trial NCT05791786?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05791786 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI